Defective Drug Newsletter

Avandia, or rosiglitazone by its generic name, is a dangerous drug used to treat Type 2 diabetes. In 2007, a scientific analysis emerged asserting that Avandia significantly increases one’s risk of heart attack or death due to heart disease. The analysis pooled the results of dozens of short-term clinical studies to reveal that Avandia increases heart attack risk by 43 percent and risk of death from heart disease by 64 percent. Another study published by the American Medical Association in 2010 showed that Avandia users are 1.27 times more likely to suffer strokes, 1.25 times more likely to experience heart failure, and 1.14 times more at risk of death than those who take Actos, a Type 2 diabetes drug in the same class as Avandia. Following these alarming studies, news reports came out in 2010 that a former U.S. Food and Drug Administration (FDA) official said the maker of Avandia, GlaxoSmithKline,…
Read More »

On December 8, a U.S. Food and Drug Administration (FDA) panel voted 21-5 that the packaging for birth control pills containing drospirenone needs to include more information about the potential risk for blood clots in the legs and lungs. Drospirenone-containing birth control pills are a new generation of “the pill” that includes Beyaz, Ocella, Zarah, Yasmin and Yaz. The FDA became concerned with Yaz and similar birth control pills after several studies indicated these drugs may increase patients’ risk for blood clots. One such study that followed 329,995 women in Israel found the blood clot risk for women taking drospirenone-containing birth control pills to be over 40 percent higher than the risk for women taking other birth control pills. Another study published by the British Medical Journal suggested these new generation birth control pills may double one’s risk of developing blood clots in the lungs. The most recent FDA-funded study…
Read More »

GlaxoSmithKline’s Advair is used to treat asthma by shrinking the swelling in the airways and relaxing and opening air passages in the lungs. In November 2005, the FDA issued a public health advisory about potentially fatal side effects from two GlaxoSmithKline asthma drugs. The agency asked the maker of the drugs, Advair Diskus and Severent Diskus, to add warnings to their labels that these medications "may increase the chance of severe asthma episodes, and death when those episodes occur." With more than $4 billion in sales, Advair was GlaxoSmithKline’s largest-selling product in the first nine months of 2005. If you or a loved one used this defective drug and there were adverse side effects, you should call us toll free now at 1-800-460-0606 because you may be entitled to compensation from the manufacturer. Your initial case evaluation and consultation is free and, if elect to take our case, you will…
Read More »

Baxter issued an urgent recall of its dialyzer, used for dialysis in kidney patients, in September 2005. The recall letter sent to customers instructed patients of the Meridian hemodialysis system to route blood tubing through only one of two channel clips to reduce the risk of kinks. The FDA classified the recall as a "Class 1," meaning that this product has been certifiably linked to serious injury and death. If you or a loved one has the Baxter Meridian Dialyzer and had adverse side effects to this defective medical device, you should call us toll free now at 1-800-460-0606 because you may be entitled to compensation from the manufacturer. It will cost you nothing to have one of our defective medical device attorneys evaluate your case, nor will you have to pay any fees or expenses out-of-pocket. All fees and expenses are paid out of any recovery we make for…
Read More »